v3.26.3
Equity Method Investments (Details) - USD ($)
2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 26, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Feb. 09, 2023
Equity Method Investment [Line Items]                
Equity method investments, net           $ 10,636,544  
Purchased interests           20,666,667    
Cash   $ 39,221   $ 39,221   109,091 2,658,182  
Preferred stock, value        
Cost of investment               $ 19,460,000
Amortization expense   563,000 1,126,000 2,158,167    
Loss from equity method investment       $ 392,677 392,677 (846,588)  
Distribution of earnings           1,745,000    
Intangible assets             8,725,712  
Goodwill   $ 12,808,197   $ 12,808,197   $ 12,808,197  
Customer Relationships [Member]                
Equity Method Investment [Line Items]                
Estimated useful life           15 years    
Series B Stated Value [Member]                
Equity Method Investment [Line Items]                
Equity method investment payable           $ 666,667    
Laboratory Services MSO [Member]                
Equity Method Investment [Line Items]                
Ownership percentage 40.00%         40.00%    
Cash           $ 9,000,000    
Amortization expense $ 111,156           666,932  
Impairment loss             259,579  
Loss from equity method investment 503,833           79,923  
Distribution of earnings $ 0           611,888  
Series B Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Preferred stock, value           $ 11,000,000  
Issuance shares (in Shares)           0 11,000  
Conversion price per share (in Dollars per share)           $ 48.2    
Series B Convertible Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Conversion price per share (in Dollars per share)           $ 1,134    
Aggregate of common stock (in Shares)           9,700    
Avalon Lab [Member]                
Equity Method Investment [Line Items]                
Total ownership percentage 40.00%              
Avalon Lab [Member] | Series B Preferred Stock [Member]                
Equity Method Investment [Line Items]                
Preferred stock, value           $ 11,000,000    
Issuance shares (in Shares)           11,000    
Avalon Lab [Member] | Series B Stated Value [Member]                
Equity Method Investment [Line Items]                
Preferred stock, value           $ 1,000    
Unrelated Company [Member]                
Equity Method Investment [Line Items]                
Total ownership percentage 60.00%